InvestorsHub Logo
Followers 0
Posts 1105
Boards Moderated 0
Alias Born 09/02/2020

Re: NanoEE post# 86380

Thursday, 03/11/2021 12:51:48 PM

Thursday, March 11, 2021 12:51:48 PM

Post# of 199213
Why would the Zhabilov Trust sell the patent when they can just make multiple license agreements?

Their current EXCLUSIVE licensing agreement with Immunotech (which was transferred completely into ENZC) has already paid out $775,000 to Zhabilov and $775,000 to Ara with 5% royalties being split between the two from the worldwide sales.

I'm sure the sub-license agreement to the subsidiary IMMB BG is being dissolved right now due to the notice of default being filed in Sofia (I'm thinking that Dimitar is either being strong-armed out of the deal or bought out by making his restricted shares into unrestricted so he can sell on the open market.) And there is likely a new sub-license agreement being made with the new subsidiary IMPL so they can commercialize in Europe (which would be sub-license to the Exclusive Licensing Agreement with Enzolytics).

Harry and the Zhabilov trust will be making money with ENZC through royalties from the ELA &&& through the increased share value between the hundreds of millions of shares that they own collectively (both common and preferred).

IMMB is completely out of the picture here and will not be receiving anything so I don't know why anyone would own shares there.

Y'all are arguing over silly things here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News